🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 18 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/08/2013 34,83 35,00 32,50 32,58 -6,75% 7,18% 1.872.300
09/08/2013 36,64 36,89 34,85 34,94 -5,18% 5,57% 1.445.800
08/08/2013 36,82 38,24 36,72 36,85 -0,05% 4,13% 940.000
07/08/2013 37,93 38,05 36,35 36,87 -3,15% 4,48% 1.162.400
06/08/2013 38,21 38,48 37,34 38,07 -0,21% 2,98% 819.600
05/08/2013 38,99 39,12 37,85 38,15 +0,05% 3,26% 1.147.900
02/08/2013 37,68 38,70 37,19 38,13 +1,68% 4,01% 1.016.100
01/08/2013 37,47 38,00 36,89 37,50 +1,41% 2,96% 1.123.200
31/07/2013 35,14 37,75 35,10 36,98 +5,03% 7,54% 1.590.200
30/07/2013 35,04 35,88 34,20 35,21 +0,28% 4,79% 1.652.400
29/07/2013 36,99 37,47 35,02 35,11 -5,01% 6,62% 1.729.400
26/07/2013 36,76 37,77 36,54 36,96 +0,16% 3,35% 1.629.800
25/07/2013 37,00 37,36 35,33 36,90 -2,07% 5,49% 5.171.600
24/07/2013 45,00 46,36 37,06 37,68 -18,85% 20,67% 13.877.100
23/07/2013 46,52 47,00 45,26 46,43 +0,17% 3,74% 1.183.500
22/07/2013 44,55 47,35 44,19 46,35 +4,51% 7,09% 1.926.300
19/07/2013 43,88 44,68 43,44 44,35 +0,93% 2,83% 1.078.900
18/07/2013 44,02 44,60 43,38 43,94 +0,07% 2,77% 838.300
17/07/2013 43,61 44,44 42,91 43,91 -0,05% 3,51% 912.000
16/07/2013 44,61 45,46 43,30 43,93 -1,52% 4,84% 1.160.500
15/07/2013 44,50 44,79 43,40 44,61 +0,63% 3,12% 825.500
12/07/2013 43,49 44,67 43,35 44,33 +1,70% 3,04% 799.300
11/07/2013 43,95 44,09 42,91 43,59 +0,55% 2,68% 953.800
10/07/2013 42,25 43,70 42,01 43,35 +2,39% 4,00% 1.058.900
09/07/2013 42,98 43,17 41,59 42,34 -0,49% 3,68% 853.000
08/07/2013 40,97 42,69 40,62 42,55 +4,62% 5,05% 1.599.400
05/07/2013 39,34 40,73 38,86 40,67 +2,68% 4,75% 1.245.500
03/07/2013 39,25 39,79 39,00 39,61 +0,61% 2,01% 428.200
02/07/2013 38,43 39,43 38,13 39,37 +2,05% 3,38% 734.700
01/07/2013 38,32 39,90 37,80 38,58 +1,42% 5,48% 1.682.200